# Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults

> **NCT00224783** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 45 (actual)

## Conditions studied

- Healthy Japanese Male Adults

## Interventions

- **BIOLOGICAL:** CAIV-T
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00224783
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2002-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224783, "Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00224783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*